La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Patrys Gestion

Gestion contrôle des critères 4/4

Le PDG Patrys' est James Campbell, nommé en Apr2015, a un mandat de 9.33 ans. La rémunération annuelle totale est A$ 735.44K, composée du salaire de 48.7% et des bonus 51.3%, y compris les actions et options de la société. détient directement 0.92% des actions de la société, d'une valeur de A$ 113.31K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 2.8 ans et 6.3 ans.

Informations clés

James Campbell

Directeur général

AU$487.1k

Rémunération totale

Pourcentage du salaire du PDG	76.5%
Durée du mandat du directeur général	9.3yrs
Propriété du PDG	0.9%
Durée moyenne d'occupation des postes de direction	2.8yrs
Durée moyenne du mandat des membres du conseil d'administration	6.3yrs

Mises à jour récentes de la gestion

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Nov 08

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Nov 09

Recent updates

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Nov 08

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

Mar 24

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Nov 09

Analyse de la rémunération des PDG

Comment la rémunération de James Campbell a-t-elle évolué par rapport aux bénéfices de Patrys?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	AU$487k	AU$373k	-AU$4m
Mar 31 2024	n/a	n/a	-AU$4m
Dec 31 2023	n/a	n/a	-AU$5m
Sep 30 2023	n/a	n/a	-AU$6m
Jun 30 2023	AU$735k	AU$358k	-AU$7m
Mar 31 2023	n/a	n/a	-AU$7m
Dec 31 2022	n/a	n/a	-AU$6m
Sep 30 2022	n/a	n/a	-AU$6m
Jun 30 2022	AU$718k	AU$327k	-AU$7m
Mar 31 2022	n/a	n/a	-AU$7m
Dec 31 2021	n/a	n/a	-AU$7m
Sep 30 2021	n/a	n/a	-AU$5m
Jun 30 2021	AU$601k	AU$325k	-AU$4m
Mar 31 2021	n/a	n/a	-AU$4m
Dec 31 2020	n/a	n/a	-AU$3m
Sep 30 2020	n/a	n/a	-AU$3m
Jun 30 2020	AU$434k	AU$318k	-AU$3m
Mar 31 2020	n/a	n/a	-AU$3m
Dec 31 2019	n/a	n/a	-AU$3m
Sep 30 2019	n/a	n/a	-AU$2m
Jun 30 2019	AU$504k	AU$305k	-AU$411k
Mar 31 2019	n/a	n/a	-AU$511k
Dec 31 2018	n/a	n/a	-AU$611k
Sep 30 2018	n/a	n/a	-AU$2m
Jun 30 2018	AU$399k	AU$280k	-AU$2m

Rémunération vs marché: La rémunération totale de James ($USD 331.03K ) est dans la moyenne des entreprises de taille similaire sur le marché Australian ($USD 300.67K ).

Rémunération et revenus: La rémunération de James a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

James Campbell

9.3yrs

Titularisation

AU$487,074

Compensation

Dr. James A. Campbell, BSc(Hons), PhD, MBA, GAICD, serves as Chief Executive Officer and Managing Director for Patrys Limited since April 13, 2015. Dr. Campbell serves as Principal of Gemini Biotechnology....

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
James Campbell	MD, CEO & Executive Director	9.3yrs	AU$487.07k	0.92% A$ 113.3k
Stefan Ross	Company Secretary	2.8yrs	AU$12.67k	pas de données
Rebecca Tunstall	Vice President of Corporate Development	2.3yrs	pas de données	pas de données

2.8yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de PAB est considérée comme expérimentée (ancienneté moyenne 2.8 ans).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
James Campbell	MD, CEO & Executive Director	9.8yrs	AU$487.07k	0.92% A$ 113.3k
Pamela M. Klein	Non-Executive Director	4.8yrs	AU$91.43k	0.012% A$ 1.5k
Peter Ordentlich	Member of Scientific Advisory Board	4.3yrs	pas de données	pas de données
Michael Stork	Non-Executive Director	17.5yrs	pas de données	4.8% A$ 592.6k
Allen Ebens	Member of Scientific Advisory Board	7.7yrs	pas de données	pas de données
Charmaine Gittleson	Chairman	1.8yrs	AU$106.94k	pas de données

6.3yrs

Durée moyenne de l'emploi

Conseil d'administration expérimenté: Les membres du conseil d'administration de PAB sont considérés comme expérimentés (ancienneté moyenne 6.3 ans).

Patrys Gestion

Gestion contrôle des critères 4/4

Informations clés

Mises à jour récentes de la gestion

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Patrys Limited Announces Retirement of Suzy Jones as Director

Patrys Limited, Annual General Meeting, Nov 15, 2023

Patrys Limited Appoints Charmaine Gittleson as the Chairman of the Board of Directors, Effective November 16, 2022

No independent directors

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Recent updates

Full year 2024 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2023)

New major risk - Market cap size

New major risk - Share price stability

New major risk - Market cap size

New major risk - Market cap size

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Patrys Limited Announces Retirement of Suzy Jones as Director

Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2022)

Patrys Limited, Annual General Meeting, Nov 15, 2023

New minor risk - Financial data availability

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

Patrys Limited Appoints Charmaine Gittleson as the Chairman of the Board of Directors, Effective November 16, 2022

No independent directors

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Patrys Limited Announces New Preclinical Data for its Full-Sized IgG Antibody, Pat-DX3

Patrys Limited, Melbourne Ordinary Shares to Be Deleted from OTC Equity

Will Patrys (ASX:PAB) Spend Its Cash Wisely?

Patrys Limited Announces Appointment of Mr. Stefan Ross as Non-Executive Director

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2021)

Patrys Limited Announces Update on PAT-DX1 From Engineering Run Meets all Specification Tests

Patrys Limited Announces New Pre-Clinical Data for Its Lead Asset, Pat-Dx1

Patrys Limited Announces Successful Completion of Pat-Dx1 Engineering Run

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

No independent directors

We're Not Very Worried About Patrys' (ASX:PAB) Cash Burn Rate

MD, CEO & Executive Director exercised options to buy AU$360k worth of stock.

Full year 2021 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2020)

Patrys Limited Provides This Interim Update on Its PAT-DX1 Clinical Trial Program

Patrys Limited Announces Full Size Deoxymab PAT-DX3 Able to Cross the Blood Brain Barrier

Patrys Limited Announces the Publication of New Preclinical Data for Its Deoxymab Antibody PAT-DX1

We're Hopeful That Patrys (ASX:PAB) Will Use Its Cash Wisely

Companies Like Patrys (ASX:PAB) Are In A Position To Invest In Growth

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2020)

Patrys Limited Successfully Establishes PAT-DX1 Stable Cell Line

What Can We Make Of Patrys' (ASX:PAB) CEO Compensation?

Patrys Limited Adds Full Human Antibody to Deoxymab Portfolio

Earnings released

Analyse de la rémunération des PDG

PDG

Titularisation

Compensation

Équipe de direction

Durée moyenne de l'emploi

Membres du conseil d'administration

Durée moyenne de l'emploi